Clinical Trial: Nationwide surveillance by the surveillance committee of Japanese Society of Chemotherapy, Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology and the Japanese Society for Infection Prevention and Control - Complicated urinary tract infection 2025- (Japan)

Tokyo, April 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061147) titled 'Nationwide surveillance by the surveillance committee of Japanese Society of Chemotherapy, Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology and the Japanese Society for Infection Prevention and Control - Complicated urinary tract infection 2025-' on April 3.

Study Type: Observational

Primary Sponsor: Institute - The Committee of Four Academic Societies Joint Antimicrobial Susceptibility Surveillance Program

Condition: Condition - Complicated urinary tract infection Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To determine the antimicrobial susceptibility of causative bacteria isolated from complicated urinary tract infection patients to various antimicrobial agents and clarify the antimicrobial resistance status Basic objectives2 - Others

Eligibility: Age-lower limit - 20 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Complicated urinary tract infection Key exclusion criteria - None Target Size - 800

Recruitment Status: Recruitment status - Open public recruiting Date of protocol fixation - 2025 Year 11 Month 13 Day Date of IRB - 2025 Year 11 Month 13 Day Anticipated trial start date - 2025 Year 11 Month 14 Day Last follow-up date - 2027 Year 12 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069973

Disclaimer: Curated by HT Syndication.